Aurinia Pharmaceuticals
AUPH
#5014
Rank
HK$10.62 B
Marketcap
HK$74.21
Share price
-0.83%
Change (1 day)
1.72%
Change (1 year)

Earnings for Aurinia Pharmaceuticals (AUPH)

Earnings in 2024 (TTM): -HK$0.12 Billion

According to Aurinia Pharmaceuticals 's latest financial reports the company's current earnings are HK$0.22 Billion. In 2023 the company made an earning of -HK$0.59 Billion, an increase over its 2022 earnings that were of -HK$0.86 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Aurinia Pharmaceuticals from 1999 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -HK$0.12 Billion-79.5%
2023 -HK$0.59 Billion-31.8%
2022 -HK$0.86 Billion-39.4%
2021 -HK$1.41 Billion61.9%
2020 -HK$0.87 Billion-9.73%
2019 -HK$0.97 Billion92.65%
2018 -HK$0.5 Billion36.39%
2017 -HK$0.37 Billion106.29%
2016 -HK$0.18 Billion-15.4%
2015 -HK$0.21 Billion65.84%
2014 -HK$0.13 Billion129.82%
2013 -HK$54.98 Million-26.6%
2012 -HK$74.91 Million
2010 -HK$42.41 Million-39.22%
2009 -HK$69.78 Million-43.78%
2008 -HK$0.13 Billion-53.19%
2007 -HK$0.27 Billion42.97%
2006 -HK$0.19 Billion-23.03%
2005 -HK$0.25 Billion36.1%
2004 -HK$0.18 Billion172.57%
2003 -HK$64.96 Million484.61%
2002 -HK$11.12 Million
2000 -HK$52.76 Million453.81%
1999 -HK$9.53 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
HK$38.61 B-32,918.65%๐Ÿ‡บ๐Ÿ‡ธ USA
-HK$42.61 Million-63.79%๐Ÿ‡บ๐Ÿ‡ธ USA
-HK$0.18 Billion 46.09%๐Ÿ‡บ๐Ÿ‡ธ USA